Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Florida · 2025 Regular Session · Bill

SB 642: Fees/Retail Sale of Ephedrine and Related Compounds

Introduced Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 642 is a bill introduced in the Florida Senate on February 11, 2025. According to its official title, it concerns: Fees/Retail Sale of Ephedrine and Related Compounds. Primary sponsor: Jonathan Martin (Republican). Most recent recorded action (February 12, 2025): Withdrawn prior to introduction.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Fees/Retail Sale of Ephedrine and Related Compounds; Requiring all covered entities, beginning on a specified date, to pay specified fees to the administrator of the electronic recordkeeping system on a monthly basis; specifying that failure to pay the fees subjects the covered entity to certain criminal penalties, etc.

Sponsors

Sponsors by party (alphabetical): Republican 1

NameRolePartyChamberDistrict
Jonathan MartinPrimary sponsorRepublicanSenate33

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Withdrawn prior to introduction
  2. Filed

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source